Sapporo, Japan

Hidematsu Hirai


Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 158(Granted Patents)


Location History:

  • Kita-ku, Sapporo-shi, Hokkaido, JP (1980)
  • Sapporo-shi, Hokkaido, JP (1982)
  • Sapporo, JP (1983 - 1985)

Company Filing History:

goldMedal3 out of 1,586 
 
Teijin Limited
 patents
silverMedal1 out of 1 
 
Hidematsu Hirai
 patent
bronzeMedal2 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1980-1985

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hidematsu Hirai: Innovator in Antitumor Therapeutics

Introduction

Hidematsu Hirai is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antitumor therapies. With a total of 4 patents to his name, Hirai's work focuses on creating conjugates and hybrids that enhance the efficacy of cancer treatments.

Latest Patents

Hirai's latest patents include groundbreaking inventions such as a conjugate having cytotoxicity and a process for its preparation. This conjugate is designed by covalently binding a polymer with cytotoxic substances to an immunoglobulin or its fragment, which selectively binds to specific antigens on target cells. Another significant patent is for an antitumor protein hybrid, which combines an antitumor immunoglobulin with a fragment of diphtheria toxin, enhancing its therapeutic potential.

Career Highlights

Throughout his career, Hidematsu Hirai has worked with prominent companies, including Teijin Limited. His innovative approaches have positioned him as a key figure in the development of advanced cancer therapies. His research has contributed to the understanding and application of targeted treatments in oncology.

Collaborations

Hirai has collaborated with esteemed colleagues such as Naoji Umemoto and Takeshi Hara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in the field of biotechnology.

Conclusion

Hidematsu Hirai's contributions to antitumor therapeutics exemplify the impact of innovation in medicine. His patents reflect a commitment to improving cancer treatment through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…